These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37890647)

  • 1. Development of long-acting injectable suspensions by continuous antisolvent crystallization: An integrated bottom-up process.
    Nandi S; Padrela L; Tajber L; Collas A
    Int J Pharm; 2023 Dec; 648():123550. PubMed ID: 37890647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Microfluidic Antisolvent Crystallization as a Bottom-Up Solution for the Development of Long-Acting Injectable Formulations.
    Nandi S; Verstrepen L; Hugo Silva M; Padrela L; Tajber L; Collas A
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bottom-up production of injectable itraconazole suspensions using membrane technology.
    Anjum F; Viville T; Nandi S; Wessner M; De Witte B; Collas A; Sadowski G
    Int J Pharm; 2024 Apr; 654():123977. PubMed ID: 38458403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of concentrated stable fenofibrate suspensions via liquid antisolvent precipitation.
    Azad MA; Knieke C; To D; Davé R
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1693-703. PubMed ID: 24102617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
    Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
    J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound.
    Jakubowska E; Milanowski B; Lulek J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of solubility enhancement of itroconazole by solid dispersion and co-crystallization technique: Investigation of simultaneous effect of media composition on drug dissolution.
    Rajbhar K; Karodadeo GR; Kumar V; Barethiya V; Lahane A; Kale S; Thakre V; Dixit G; Kohale N; Hiradeve S; Rarokar NR
    Ann Pharm Fr; 2023 Sep; 81(5):843-855. PubMed ID: 37182590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.
    Bao Q; Zou Y; Wang Y; Choi S; Burgess DJ
    AAPS J; 2021 Mar; 23(2):42. PubMed ID: 33709196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of itraconazole nano-co-crystals into multiparticulate oral dosage forms.
    Huang Z; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2022 Jul; 176():75-86. PubMed ID: 35598769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Nanomedicine; 2012; 7():5475-89. PubMed ID: 23093903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
    Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
    Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.
    Bosselmann S; Nagao M; Chow KT; Williams RO
    AAPS PharmSciTech; 2012 Sep; 13(3):949-60. PubMed ID: 22752680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B; Liu S; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring the use of excipients in bottom-up production of naproxen crystal suspensions via membrane technology.
    Anjum F; Wessner M; De Witte B; Al-Rifai N; Collas A; Sadowski G
    Int J Pharm; 2024 Mar; 652():123846. PubMed ID: 38272195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.